Correction to: Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features
Crossref DOI link: https://doi.org/10.1007/s11523-021-00864-9
Published Online: 2021-12-24
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shirley, Matt
Text and Data Mining valid from 2021-12-24
Version of Record valid from 2021-12-24
Article History
First Online: 24 December 2021
Change Date: 8 January 2022
Change Type: Update
Change Details: Funder update